Online Information Increases Physical Activity Among T2D Patients
Study results showed that access to online information specific to the condition can increase physical activity.
Read More
NIH Funds Study on Neonatal Opioid Withdrawal Treatment Options
Neonatal opioid withdrawal incidences have increased 300% since 1999, along with the rising use of opioids, making the risk for the condition more prevalent than ever.
Janssen Files sNDA for Canagliflozin for Cardiovascular Risk Reduction
The sNDA is seeking an indication for the reduction of major adverse events, including cardiovascular death, myocardial infarction, and stroke.
PnuVax Receives $29.4M Grant for Pneumonia Vaccine
The Canadian-based pharmaceutical company plans to produce a low-cost, multi-strain coverage vaccine with the grant.
NEI Awards $90K for Proposal for 3D Printing Human Retina
The Erin Lavik-led team's proposal included screen-printing layers of adult neural progenitor-derived retinal neurons that parallel the human retina structure.
FDA Approves Fast-Acting Insulin Aspart for Diabetes Treatment
The Novo Nordisk product showed a greater reduction in overall blood sugar compared to the conventional insulin in clinical trials.
Dravet Syndrome Treatment Returns Positive Results in Phase 3 Study
The treatment for Dravet syndrome showed 63.9% average reduction in monthly seizures, as well as a seizure-free period at 20.5 days.
Adalimumab Prolonged Dosing Regimen Proves Safe for RA
Improvement in DAS28 scores was statistically significant in 26% of patients using adalimumab every 3 weeks compared to every 2 weeks.
FDA Advisory Committee Votes for More Data on Duchenne Treatment
Data on ataluren, a first-in-class oral treatment for Duchenne muscular dystrophy, was considered inconclusive by a vote of 10-1.
Death, Cardiovascular Events Reduced by Nonrecreational Activity
PURE study results showed that patients who met or exceeded recommended physical activity guidelines had a lower risk of CV events and mortality.
FDA Gives Nod to FreeStyle Libre Glucose Monitoring System
The FreeStyle Libre Flash Glucose Monitoring System reduces the requirement of “fingerstick” testing, with small sensor wire that continuously monitors and measures levels.
Resistance Training Shows Positive Physical, Neurological Effects on MS Patients
The results of 2 studies determined that resistance training can improve lower limb function and cortical thickness in MS patients.
Diabetic Retinopathy Risk Reduced by RYGB Surgery
The patients who received RYGB surgery had a 60% better chance of unchanged or improved diabetic retinopathy than those without the operation.
Asthma Treatment Linked to Nightmares, Depression in Children and Adults
In total, 774 cases of nightmares were reported, with 467 of the cases occurring in patients aged 19 years and younger using montelukast.
Mallinckrodt Announces 6-Point Initiative to Combat Opioid Epidemic
The company's 6 points include educating providers and the public, funding programs to aid prevention, and advocating for the use of alternative therapies.
Guanfacine Meets Phase 3 Endpoints for ADHD in Adults
The drug is being tested for the first time on a large scale adult patient population.
FDA, Interpol Crack Down on Illegal Online Pharmacies
In the crackdown, nearly 100 website domains were seized by the FDA and partnered law enforcement.
Reduced Asthma Risk Linked to Infant Exposure to Pet, Pest Allergens
The URECA showed that early exposure to cat, mouse, and cockroach allergens can reduce the risk of asthma by age 7.
Digital Therapy Management Aids in Maintaining A1C Reduction
The Glucommander software showed patients were able to rapidly control their glucose levels and maintain their control long-term.
FDA Issues Response Letter to Janssen for RA Therapy Sirukumab
The response letter indicated the need for additional clinical data in order to further evaluate sirukumab's safety profile.
Subcutaneous Furosemide: Taking Diuresis Outside the Hospital
The sc2Wear Infusor allows the opportunity to deliver furosemide subcutaneously and at home, to keep HF patients in need of diuresis out of the hospital.
Hofstra Northwell: IMPACcT Program Promotes Team-Based Primary Care
Anacetrapib Meets Primary Endpoint, But Its Future is Called into Question
FDA Approval of Betrixaban Could Potentially Alter the Future of VTE Treatment
FDA Gives Nod to Updated Duodenoscope Design
The ED34-i10T model includes a single-use, detachable and disposable distal cap, a simplified interface, ergonomic and image quality improvements, and reduced length.
Low-Dose Dopamine Has Insignificant Impact on Renal Function, Diuresis
The ROPA-DOP trial showed that low-dose dopamine had an insignificant impact on patient renal function, nor a significant trend toward greater diuresis.
Scott Solomon, MD, and Alvin Chandra, MD: The PARADIGM-HF and QoL Trial
Scott Solomon, MD, and Alvin Chandra, MD, discuss the findings of the PARADIGM-HF and QoL trial, and sacubitril's effect on HF patients quality of life.
Michael Felker, MD: The GUIDE-IT Trial
Michael Felker, MD, talks about the results of the GUIDE-IT trial and the use of natriuretic peptide-guided therapy for patients with HFrEF.
Lisa Rathman, MSN: The Benefits of Subcutaneous Furosemide in Nursing Homes
Lisa Rathman, MSN, of Lancaster General Hospital, discusses the benefits of subcutaneous furosemide in nursing homes and facilities outside the hospital.
Physician Roll Call: SGLT2 Inhibitors for Treatment of Heart Failure
Gregg Fonarow, MD; David Aguilar, MD; Rob Mentz, MD; and James Januzzi, MD, discuss the unexpected and exciting use of SGLT-2 inhibitors to treat heart failure.